热门资讯> 正文
Artelo Biosciences GAAP每股收益为3.97美元
2025-11-12 22:28
- Artelo Biosciences press release (ARTL): Q3 GAAP EPS of $3.97.
- In September 2025, the Company completed a confidentially marketed public offering of common stock with gross proceeds of $3.0 million.
More on Artelo Biosciences
- Artelo Biosciences prices $2 million public offering; shares down over 24%
- Artelo Biosciences announces pricing of $3 million public offering
- Seeking Alpha’s Quant Rating on Artelo Biosciences
- Financial information for Artelo Biosciences
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
